Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ESTRADIOL AND NORGESTIMATE

ESTRADIOL; NORGESTIMATE

Standard Dose
1MG,1MG;N/A,0.09MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ESTRADIOL AND NORGESTIMATE is listed in Drugs@FDA under application 076812 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTRADIOL; NORGESTIMATE Form and strength TABLET;ORAL - 1MG,1MG;N/A,0.09MG Sponsor BARR Submission history Latest submission status date: 2025-01-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESTRADIOL AND NORGESTIMATE is listed in Drugs@FDA under application 076812 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTRADIOL; NORGESTIMATE Form and strength TABLET;ORAL - 1MG,1MG;N/A,0.09MG Sponsor BARR Submission history Latest submission status date: 2025-01-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ESTRADIOL AND NORGESTIMATE (ESTRADIOL; NORGESTIMATE) | Drug Monograph | MedicHelpline